These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12577293)

  • 1. Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging.
    Rijpkema M; Schuuring J; van der Meulen Y; van der Graaf M; Bernsen H; Boerman R; van der Kogel A; Heerschap A
    NMR Biomed; 2003 Feb; 16(1):12-8. PubMed ID: 12577293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
    Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
    J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
    Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
    Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
    Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
    Brain; 2001 Feb; 124(Pt 2):427-36. PubMed ID: 11157569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.
    Vuori K; Kankaanranta L; Häkkinen AM; Gaily E; Valanne L; Granström ML; Joensuu H; Blomstedt G; Paetau A; Lundbom N
    Radiology; 2004 Mar; 230(3):703-8. PubMed ID: 14739313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.
    Zhuang Z; Qi M; Li J; Okamoto H; Xu DS; Iyer RR; Lu J; Yang C; Weil RJ; Vortmeyer A; Lonser RR
    J Neurosurg; 2011 Oct; 115(4):789-95. PubMed ID: 21682567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between oligodendroglioma genotypes using dynamic susceptibility contrast perfusion-weighted imaging and proton MR spectroscopy.
    Chawla S; Krejza J; Vossough A; Zhang Y; Kapoor GS; Wang S; O'Rourke DM; Melhem ER; Poptani H
    AJNR Am J Neuroradiol; 2013 Aug; 34(8):1542-9. PubMed ID: 23370479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading of oligodendroglial tumors of the brain with apparent diffusion coefficient, magnetic resonance spectroscopy, and dynamic susceptibility contrast imaging.
    Naveed MA; Goyal P; Malhotra A; Liu X; Gupta S; Mangla M; Mangla R
    Neuroradiol J; 2018 Aug; 31(4):379-385. PubMed ID: 29469659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton magnetic resonance spectroscopy (1H-MRS) for the diagnosis of brain tumors and the evaluation of treatment].
    Grand S; Tropres I; Hoffmann D; Ziegler A; Le Bas JF
    Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):299-308. PubMed ID: 16292174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [1H magnetic resonance spectroscopy in intracranial tumors and cerebral ischemia].
    Felber SR
    Radiologe; 1993 Nov; 33(11):626-32. PubMed ID: 8278589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
    Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
    Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.
    Howe FA; Barton SJ; Cudlip SA; Stubbs M; Saunders DE; Murphy M; Wilkins P; Opstad KS; Doyle VL; McLean MA; Bell BA; Griffiths JR
    Magn Reson Med; 2003 Feb; 49(2):223-32. PubMed ID: 12541241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors.
    Tien RD; Lai PH; Smith JS; Lazeyras F
    AJR Am J Roentgenol; 1996 Jul; 167(1):201-9. PubMed ID: 8659372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo short echo time 1H-magnetic resonance spectroscopic imaging (MRSI) of the temporal lobes.
    McLean MA; Woermann FG; Simister RJ; Barker GJ; Duncan JS
    Neuroimage; 2001 Aug; 14(2):501-9. PubMed ID: 11467922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.
    Hagberg G; Burlina AP; Mader I; Roser W; Radue EW; Seelig J
    Magn Reson Med; 1995 Aug; 34(2):242-52. PubMed ID: 7476084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors.
    Spampinato MV; Smith JK; Kwock L; Ewend M; Grimme JD; Camacho DL; Castillo M
    AJR Am J Roentgenol; 2007 Jan; 188(1):204-12. PubMed ID: 17179366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.